Wall Street Breakfast
Wall Street Breakfast
Seeking Alpha
Moderna's good news goes bad
4 minutes Posted Oct 23, 2026 at 10:37 am.
Moderna's (MRNA) cancer vaccine clears a hurdle, but the stock hits a wall.
Tower stocks (CCI) (AMT) soar as investors size up a major opportunity.
Kohl's (KSS) gets a rare buy rating.
0:00
4:40
Download MP3
Show notes
Moderna's (MRNA) cancer vaccine clears a hurdle, but the stock hits a wall. (00:13) Tower stocks (CCI) (AMT) soar as investors size up a major opportunity. (01:29) Kohl's (KSS) gets a rare buy rating. (02:25) Episode transcripts seekingalpha.com/wsb.Show links:Biggest stock movers Friday: SKHY, MRNA, DECK, and moreSign up for our daily newsletter here and for full access to analyst ratings, stock quant scores, dividend grades, subscribe to Seeking Alpha Premium at seekingalpha.com/subscriptions.